Pernix Therapeutics Holdings, Inc.
(NASDAQ : PTX)

( )
PTX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
1.53%16.612.0%$163.34m
PRGOPerrigo Co. Plc
-1.50%44.526.8%$125.64m
SAGESAGE Therapeutics, Inc.
2.77%135.609.5%$118.42m
JAZZJazz Pharmaceuticals Plc
0.13%128.172.2%$94.28m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.05%128.616.3%$74.28m
PTLAPortola Pharmaceuticals, Inc.
2.37%25.537.7%$61.81m
ICPTIntercept Pharmaceuticals, Inc.
-1.13%110.8018.6%$54.35m
MNKMallinckrodt Plc
0.30%20.0121.1%$45.03m
CTLTCatalent Inc
1.67%34.642.4%$41.21m
AXSMAxsome Therapeutics, Inc.
1.51%8.062.7%$40.50m
UTHRUnited Therapeutics Corporation
-1.16%113.6214.4%$39.59m
ICLRICON Plc
-1.85%133.804.1%$39.58m
ENDPEndo International Plc
0.31%9.668.9%$36.88m
HZNPHorizon Pharma plc
-1.04%21.927.4%$30.81m
MDCOMedicines Company
-0.20%19.8021.8%$29.37m

Company Profile

Pernix Therapeutics Holdings, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It focuses on therapeutics for diseases on central nervous system, neurology, pain, and psychiatry. Its products include treatment of migraine pain and inflammation, insomnia, and depressive disorder. It distributes products through the following brands: Treximet, Silenor, and Zohydro ER with BeadTek. The company was founded in 1996 and is headquartered in Morristown, NJ.